Healthcare


 Cynata Therapeutics Cymerus™ technology to be featured in ISCT presentations

Cynata Therapeutics Cymerus™ technology to be featured in ISCT presentations

May 31, 2019 03:05 PM AEST| By Team Kalkine Media

Cynata Therapeutics Limited (ASX: CYP) is a clinical-stage stem cell and regenerative medicine company. Based in Australia, it aims to develop therapies based on Cymerus?. This is a proprietary therapeutic stem cell platform technology. The technolog...

 Patrys Releases Pre-clinical Animal Data for Lead Candidate, PAT-DX1

Patrys Releases Pre-clinical Animal Data for Lead Candidate, PAT-DX1

May 31, 2019 12:55 PM AEST| By Team Kalkine Media

Patrys Limited (ASX: PAB), based in Melbourne, Australia, is a healthcare sector company focused on the development of therapeutic antibodies to treat a range of cancers and their subtypes. Some of its products in the pipeline and at different stages...

 Mesoblast Limited Initiated The Rolling Submission Of BLA For GvHD

Mesoblast Limited Initiated The Rolling Submission Of BLA For GvHD

May 30, 2019 11:23 PM AEST| By Team Kalkine Media

Cellular medicines developer, Mesoblast Limited (ASX: MSB) has achieved a major corporate milestone by filing the first component of a rolling submission for a Biologics License Application to U.S. Food and Drug Administration for its lead product ca...

 3 Exciting Stocks in Health Care Space - PAR, NOX, RNO

3 Exciting Stocks in Health Care Space - PAR, NOX, RNO

May 30, 2019 11:20 PM AEST| By Team Kalkine Media

Paradigm Biopharmaceuticals Limited: Paradigm Biopharmaceuticals Limited (ASX: PAR) is an Australian biopharmaceutical company. The company is into the R&D of therapeutic products for human use. It also focusses on repurposing pentosan polysulph...

 A Glimpse At Biotech Company, Imugene Limited

A Glimpse At Biotech Company, Imugene Limited

May 30, 2019 05:34 PM AEST| By Team Kalkine Media

A biotechnology company with operations in America and Europe, Imugene Limited (ASX: IMU) deals with the development of cancer immunotherapies targeting B-cell peptide vaccines. The company?s product pipeline comprises of multiple immunotherapy B-cel...

 ResApp Health Onboarded UK-Consultancy Firm; Two CE-marked Devices to be Finalised

ResApp Health Onboarded UK-Consultancy Firm; Two CE-marked Devices to be Finalised

May 30, 2019 01:06 PM AEST| By Team Kalkine Media

ResApp Health Limited (ASX: RAP) is a leading digital health company. It focusses on making smartphone applications for the management and diagnosis of respiratory diseases. Its machine learning algorithms make use of sound to spot and calculate the...

 A Glance At Medical Technology Company, LBT Innovations Limited

A Glance At Medical Technology Company, LBT Innovations Limited

May 29, 2019 04:00 PM AEST| By Team Kalkine Media

LBT Innovations Limited (ASX: LBT) is a medical technology company based in Adelaide, South Australia and is engaged in the development of world?s leading products in microbiology automation. The company offers advanced technology solutions to the he...

 Bionomics Announces Strategic Review Results; Shares Slipped On ASX

Bionomics Announces Strategic Review Results; Shares Slipped On ASX

May 29, 2019 03:13 PM AEST| By Team Kalkine Media

Bionomics Limited (ASX: BNO) is involved in the healthcare sector. It is a global, clinical stage biopharmaceutical company focused on developing better treatments for central nervous system disorders, including anxiety, depression and Alzheimer?s di...

 A look at SUDA Pharmaceuticals’ Product Portfolio

A look at SUDA Pharmaceuticals’ Product Portfolio

May 29, 2019 03:04 PM AEST| By Team Kalkine Media

Headquartered in Western Australia, SUDA Pharmaceuticals Ltd (ASX: SUD) is a drug-delivery pharmaceutical company that develops low-risk, innovative pharmaceuticals to improve the health and lifestyle of patients, by utilising its OroMist? oro-mucosa...

 Paradigm Announces Positive Results for iPPS; Stock Continues To Consolidate

Paradigm Announces Positive Results for iPPS; Stock Continues To Consolidate

May 29, 2019 02:48 PM AEST| By Team Kalkine Media

Paradigm Biopharmaceuticals Limited (ASX: PAR) is a healthcare company which is focused on repurposing a FDA approved drug; injectable Pentosan Polysulfate Sodium (iPPS), having safe history of 60+ years for treating inflammation. Recently the compa...

 Cellmid Updated on FY2020 Growth Strategy; Co-Subsidiary Appointed CEO

Cellmid Updated on FY2020 Growth Strategy; Co-Subsidiary Appointed CEO

May 29, 2019 01:33 PM AEST| By Team Kalkine Media

Cellmid Limited (ASX: CDY) is an Australian life sciences company from the Health Care sector, which develops products to treat cancer and chronic inflammatory diseases. On 28 May 2019, the company also provided an update on the FY2020 growth strate...

 ImExHS Secures Contract Extension with its major Columbia-based client

ImExHS Secures Contract Extension with its major Columbia-based client

May 29, 2019 12:58 PM AEST| By Team Kalkine Media

ImExHS Limited (ASX: IME) reported that a prominent privately-owned hospital, Promotora Medica De Las Americas S.A. - ?Cl?nica Las Americas? extended and amended ImExHS HIRUKO? RIS/PACS multi-site contract for an additional six years. The contract al...

 Medlab Clinical Executes HOA With A Thai Pharmaceutical Company; Price Volatility Is Back

Medlab Clinical Executes HOA With A Thai Pharmaceutical Company; Price Volatility Is Back

May 28, 2019 10:32 PM AEST| By Team Kalkine Media

Medlab Clinical Limited (ASX: MDC) is an ASX listed healthcare company which is developing therapeutic pathways for diagnosed chronic diseases. The company has also moved forward developing therapies for obesity, depression and pain management. It is...

 Orthocell’s Securities Placed In Trading Halt, AU$10 Mn Capital Raising Planned

Orthocell’s Securities Placed In Trading Halt, AU$10 Mn Capital Raising Planned

May 28, 2019 10:23 PM AEST| By Team Kalkine Media

Orthocell Limited (ASX: OCC) is a world leading regenerative medicine company based in Murdoch, Australia.? The healthcare sector player develops and commercialises cell therapies and products for the repairment of soft tissue injuries, thus supporti...

 PainChek® Signs A BDA With Person Centred Software; Momentum Indicator RSI Off The Charts!

PainChek® Signs A BDA With Person Centred Software; Momentum Indicator RSI Off The Charts!

May 28, 2019 07:59 PM AEST| By Team Kalkine Media

PainChek Ltd (ASX: PCK) is an ASX listed healthcare company which uses facial recognition software to detect the presence of facial micro-expressions from a small video of the person, taken from a smartphone in real time. Due to its reproducibility,...

 Telix Requested FDA for NDA Meeting; Added 2 New Partners in the US

Telix Requested FDA for NDA Meeting; Added 2 New Partners in the US

May 28, 2019 03:48 PM AEST| By Team Kalkine Media

Telix Pharmaceuticals Limited (ASX: TLX) is a global biopharmaceutical company based in Melbourne. The company develops diagnostic and therapeutic products. Its focus is on radiopharmaceuticals or molecularly targeted radiation. TLX globally operates...

 All that investors need to know about clinical stage oncology company, Prescient Therapeutics

All that investors need to know about clinical stage oncology company, Prescient Therapeutics

May 28, 2019 03:44 PM AEST| By Team Kalkine Media

Prescient Therapeutics Limited (ASX: PTX), based in South Melbourne, Australia, is an oncology company (clinical-stage) that develops novel drugs and targeted therapies to treat specific mutations that stimulate cancer and thus, contribute to resista...

 THC Global Chairman: THC Is Far Stronger Than It Was 12 Months Ago

THC Global Chairman: THC Is Far Stronger Than It Was 12 Months Ago

May 28, 2019 02:17 PM AEST| By Team Kalkine Media

Medicinal cannabis product company, THC Global Group Limited (ASX: THC) released its chairman address, which is to be presented in the 2019 Annual General Meeting scheduled to be held today, i.e., 28 May 2019. THC Global functions as a ?Farm to Phar...

 Dimerix Ltd Issues DMX-200 Manufacturing Update; Commercial Scale Production in FY2020

Dimerix Ltd Issues DMX-200 Manufacturing Update; Commercial Scale Production in FY2020

May 28, 2019 12:39 PM AEST| By Team Kalkine Media

Dimerix Limited (ASX: DXB) is a clinical-stage biopharmaceutical company. It develops innovative therapies for medical needs that have not been met with. DXB caters to global markets. Presently, the company is developing its proprietary product, DMX-...

 Fisher & Paykel Healthcare Achieved Revenue Milestone of NZ$1 Billion in FY19

Fisher & Paykel Healthcare Achieved Revenue Milestone of NZ$1 Billion in FY19

May 27, 2019 05:16 PM AEST| By Team Kalkine Media

Fisher & Paykel Healthcare Corporation Limited (ASX: FPH) is primarily involved in designing innovative products for respiratory care. The company help patients transition to less acute care settings, help them recover more quickly and provide so...

AU_advertise

Advertise your brand on Kalkine Media

Recent Articles






Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.